Retail Roundup

Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

States permitting the use of medical marijuana have found decreases in opioid overdose deaths and use of opioids for chronic pain. A recent report found that between 1999 and 2010, states that permitted medical marijuana use ha...

View Blog Post
Blog Post

A recent study by Massachusetts General Hospital in Boston discovered that medication errors or adverse drug events had occurred during around half of surgeries occurring over 7 months from 2013-2014. According to a

View Blog Post
Blog Post

Three recent reports examined the issue of leftover prescription opioids and the effectiveness of community drug disposal programs. The first report showed that opioid prescriptions returned for disposal had greater than 60% of th...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up